Shorla Pharma develops and commercializes innovative drugs in the oncology space for women’s and pediatric cancers. The company focuses on indications where existing treatments are limited, in shortage or inadequate for the target population.
Its products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments.
Shorla’s growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical impact.
Jul 16, 2021
Posted by Shorla Oncology